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SUMMARY
The proteins gag-24 (HIV-1), and a representative region 
of the gp-41 (HIV-1), gp-36 (HIV-2), and gp-120 (HIV-1) 
were expressed in Escherichia coli under control of the 
tryptophan promoter. 
The influence of the induction conditions on cellular growth 
and protein expression were evaluated, and taken into ac-
count for establishing the final culture conditions. Different 
concentration of 3-ß Indoleacrylic Acid (IA between 0 to 
60 mg/ml) and tryptophan (from 0 to 100 mg/ml) on growth 
and expression level, was evaluated for the four expres-
sed recombinant proteins, using the same plasmid, culture 
medium, and growth conditions at shake flasks level.
The expression level achieved for each recombinant protein 
depended on the induction conditions. 
The results suggest that there is not a predetermined rule 
about the induction conditions to achieve high level expres-
sion of recombinant proteins expressed under tryptophan 
promoter. Finally we decided to carry out the production 
of the proteins by derepresion of the expression system, 
without the use of tryptophan in the cultivation medium. The 
levels of expression obtained with these clones were higher 
than 15% for each one of the tested proteins. These results 
are very superior to those reported previously for the several 
proteins of the HIV. These procedures could be also applied 
to evaluate the expression of other recombinant proteins ex-
pressed in E. coli under the control of tryptophan promoter.
Key words: E.coli, 3-ß Indoleacrylic Acid, Induction strate-
gy, Recombinant proteins, Tryptophan promoter.
RESUMEN
Las proteínas gag-24 (VIH-1) y una región representativa 
de la gp-41 (VIH-1), gp-36 (VIH-2) y gp-120 (VIH-1) fueron 
expresadas en Escherichia coli bajo control del promotor 
del triptófano. 
La influencia de las condiciones de inducción en el creci-
miento celular y la expresión de las proteínas fueron eva-
luadas y tomadas en cuenta para el establecimiento de las 
condiciones de cultivo final. Se evaluaron diferentes con-
centraciones de ácido 3-ß Indolacrílico (entre 0 a 60 mg/ml) 
y triptófano (de 0 a 100 mg/ml) sobre el nivel de crecimien-
to y de expresión para las cuatro proteínas recombinan-
tes expresadas, utilizando en todos los casos las mismas 
condiciones (plasmídio, medio de cultivo y condiciones de 
crecimiento) a nivel de zaranda. 
El nivel de expresión alcanzado para cada proteína recom-
binante dependió de las condiciones de inducción. 
Los resultados sugieren que no existe una regla predeter-
minada sobre las condiciones de inducción para alcanzar 
altos niveles de expresión de las proteínas recombinantes 
expresadas bajo el promotor del triptófano. Finalmente 
decidimos llevar a cabo la producción de las proteínas por 
derepresión del sistema de expresión, sin el uso de trip-
tófano en el medio de cultivo. Los niveles de expresión 
obtenidos con estos clones fueron superiores a 15% para 
cada una de las proteínas evaluadas. Estos resultados 
son muy superiores a los reportados previamente para las 
proteínas del VIH. Estos procedimientos también podrían 
aplicarse para evaluar la expresión de otras proteínas re-
combinantes expresada en E. coli bajo el control del pro-
motor triptófano.
Palabras clave: E. coli; ácido 3-ß indolacrílico; estrategia 
de inducción; proteínas recombinantes; promotor triptó-
fano.
RESUM
Les proteïnes gag-24 (VIH-1) i una regió representativa de 
la gp-41 (VIH-1), gp-36 (VIH-2) i gp-120 (VIH-1) van ser 
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expressades en Escherichia coli sota control del promotor 
del triptòfan.
La influència de les condicions d’inducció en el creixe-
ment cel·lular i l’expressió de les proteïnes van ser avalua-
des i considerades per a l’establiment de les condicions 
del conreu final. Es van avaluar diferents concentracions 
d’àcid 3-ß Indolacrílic (entre 0 i 60 mg/ml) i del triptòfan 
(entre 0 i 100 mg/ml) en relació al nivell de creixement i 
d’expressió per a les quatre proteïnes recombinants ex-
pressades, utilitzant en tots els casos les mateixes condi-
cions (plasmidi, medi de cultiu i condicions de creixement) 
a nivell de garbell.
El nivell d’expressió assolit per a cada proteïna recombi-
nant depenia de les condicions d’inducció.
Els resultats suggereixen que no hi ha una regla per defec-
te sobre les condicions d’inducció per assolir alts nivells 
d’expressió de les proteïnes recombinants expressades 
sota el promotor del triptòfan. Finalment vam decidir dur a 
terme la producció de proteïnes per repressió del sistema 
d’expressió, sense l’ús de triptòfan en el medi de cultiu. 
Els nivells d’expressió obtinguts amb aquests clons van 
ser superiors al 15% per a cadascuna de les proteïnes 
avaluades. Aquests resultats són molt superiors als repor-
tats prèviament per les proteïnes del VIH. Aquests proce-
diments també es podrien aplicar per avaluar l’expressió 
d’altres proteïnes recombinants expressada en E. coli sota 
el control del promotor triptòfan.
Paraules clau: E. coli; àcid 3-ß indolacrílic; estratègia 
d’inducció; proteïnes recombinants; promotor triptòfan. 
INTRODUCTION
Achieving high expression levels of target protein is one of the 
main objectives in the cultivation of recombinant cells. This 
objective may be accomplished through to two complemen-
tary approaches, namely, genetic engineering and optimal 
induction. However, combined effects (medium composi-
tion, induction strategy, etc), that result in optimal expression 
or product stability, may not be predictable based upon host 
strain type or plasmid construction and may be achieved us-
ing widely differing fermentation conditions.
Regulated promoters are most commonly used to allow 
control of the cloned-gene expression level by manipu-
lation of environmental parameters. Different ways of in-
ducing the expression of heterologous proteins cloned in 
E.coli under the ptrp system have been reported in the 
specialized literature. The most commonly used method 
is the use of competitive agents analogous to tryptophan, 
such as of 3-ß Indoleacrylic Acid (IA) and Indolyl-3-propi-
onic acid (1, 2). The ptrp promoter can also be induced by 
derepression when the tryptophan present in the culture 
medium is depleted during the fermentation process (3).
The trp promoter (tryptophan) is a strong and widely used. 
It is negatively regulated by repressor trp protein complex 
and the derrepresion is produced by the absence of tryp-
tophan in the culture medium or the addition of an induc-
tor, 3 b-Indoleacrylic acid (4).  
The tryptophan synthesis in bacteria such as E. coli is pri-
marily controlled through feedback inhibitions of the end 
product tryptophan on the enzymes at metabolic level and 
repression of the trp operon at transcriptional level. Previ-
ous studies revealed that termination of the operon tran-
scription by attenuation also occurs at a lower intracellular 
concentration of tryptophan (5). Attenuation is the con-
junction of processes of transcription and translation and 
brings about a finer control for the regulation of transcrip-
tion in the tryptophan biosynthetic pathway. It is a tryp-
tophan-sensitive timing mechanism that determines whe-
ther transcription is attenuated or allowed to continue. The 
trp operon attenuation is defined by the concentrations of 
charged tryptophan tRNA (Trp-tRNATrp). When the trypto-
phan concentration is high, the concentration of Trp-tR-
NATrp is also high. Translation will follow closely on the 
heels of transcription, proceeding rapidly past the Trp co-
dons; the attenuator structure is formed and transcription 
is halted. When tryptophan concentrations are low, how-
ever, the ribosome stalls at the two Trp codons because 
charged tRNATrp is unavailable; a base paired structure is 
formed and prevents attenuation; transcription continues 
to proceed but translation stops as a result of a lack of 
tryptophan (6). The joint action of these three regulation 
mechanisms including feedback inhibition, repression and 
attenuation is believed to give rise to complicated dynamic 
behaviors such as oscillations (7).
In some genetic constructions used for the expression of 
recombinant proteins under the promoter trp it is neces-
sary to add 3-ß Indoleacrylic Acid for the induction of the pro-
moter. This inductor competes with the present tryptophan 
for the repressor and the complex oppressor-indoleacrylic 
is not recognized by the operator, which will increase the 
transcription of the gene (8).
Several heterologous proteins have been cloned under the 
control of tryptophan promoter: Human Epidermal Growth 
Factor (1), ß-Galactosidase (9), Calf Chymosin (10), but in 
very few reports, the authors studied the effect of the in-
duction conditions on the cellular growth and the protein 
expression kinetics (11).
In this report, the effect of the induction conditions (IA and 
tryptophan concentration) on the production of four diffe-
rent recombinant proteins expressed in E. coli under the 
control of tryptophan promoter, using the same plasmid, 
culture medium, and growth conditions were studied. 
MATERIALS AND METHODS
E coli host strains and expression plasmid
The following E. coli recombinant strains were used: HB-
101 (pHIVCA-1), W-3110 (pHIVTA-1), C-600 (pHIVTA-2), 
and W-3110 (pIT 120) (12). These strains have been used 
for the expression of gag-24 (HIV-1), and a representative 
region of the gp-41 (HIV-1), gp-36 (HIV-2) (13), and gp-120 
(HIV-1) proteins (14), under the control of the tryptophan 
promoter. The pFP15 was used as basal plasmid to all 
constructions (13). 
Media composition and culture conditions
Cultures were performed in shake flasks (G-25, New Brun-
swick Scientific Co, INC, E.U.), using M9 medium (15) sup-
plemented with glucose 20 g/l, casein hydrolysate 10 g/l, 
and ampicillin 50 mg/ml. Cultivations were performed at a 
temperature of 37oC and stirrer speed of 250 rpm. The 
pH was not controlled and culture time was 12 hours. 
The effect of IA concentration was determined by adding 
20 mg/ml of tryptophan to the culture medium, and dif-
ferent concentrations of IA (between 0 to 60 mg/ml) were 
added after 1hour of cultivation. The influence of the initial 
tryptophan concentrations (from 0 to 100 mg/ml) on protein 
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expression was studied in the absence of IA in the culture 
medium. 
Analytical methods
Cell growth was determined by measuring optical densi-
ty at 530 nm using a spectrophotometer GENESYS 10UV 
(Electron Corporation, USA).
The total protein concentration present in whole cell ex-
tracts was determined by the Lowry and collaborators 
method using as pattern protein albumin from bovine se-
rum (Merck) (16). 
Polyacrylamide gel electrophoresis was performed by the 
method described by Laemmli (1970) (17). In all cases 
were applied 20 ug of total protein in each line of electro-
phoresis. The samples were processed in the buffer Tris-
HCl 125 mM pH 6.8, 4% (w/v) SDS, glycerol 20% (w/v), 
125 mM DTT, to 100oC for 15 minutes and were applied 
in a polyacrylamide gel 15% finally stained with a solution 
of Coomassie Blue. As patterns of molecular weight were 
used: phosphorylase b (97 kDa), bovine serum albumin (67 
kDa), ovalbumin (43 kDa), carbonic anhydrase (30 kDa), 
trypsin inhibitor (21 kDa) and lysozyme (14 kDa).
In all cases expression level (%) of each protein present in 
whole cell extracts was determined by densitometric ana-
lysis of SDS-PAGE using a Densitometer GS-800, BioRad 
(SoftWare ¨Quantity One   4.6.5¨, The Discoverys Series). 
In all cases expression level (%) of each protein was de-
termined by comparing the percentage that represents 
the band-specific of the recombinant protein expressed in 
each case with the total of proteins (100%) detected by 
the Densitometer in each line of electrophoresis.
All reagents used in the preparation of the solutions for the 
different processes, were of quality for analysis. 
In all experiments at least 3 assays were carried out.
RESULTS AND DISCUSSION
In this work the tryptophan promoter was used, conside-
ring the literature reports that the expression of genes un-
der this promotion signal leads to high expression levels in 
a relatively simple form (18). As has been reported in the 
literature, the behavior of the expression of recombinant 
proteins expressed under the control of the tryptophan 
promoter depend on a series of factors, like for example, 
the composition of the cultural medium used, the con-
ditions of cultivation including the aeration, the agitation 
level, the temperature, and the pH of growth. (1, 11, 19).  
The effect of inductor concentration on the production of 
four different recombinant proteins in shake flasks was de-
termined. In all cases, when the inductor concentrations 
was increased, only a slight reduction on cellular growth 
was observed (Figure 1a), and optical density was maxi-
mal in absence of IA. Figure 1b shows that in the case of 
the gp-120 and gp-36 the level of expression (49% and 
10%, respectively), did not increase in the presence of dif-
ferent IA concentrations. 
The expression level of gag-24 is a function of the amount 
of inductor utilized; using 60 mg/ml of IA, 30% of expression 
was obtained. When the process was done in the absence 
of IA, the expression of gp-41 was almost not detected, 
while using concentrations higher than 20 mg/ml the expres-
sion was constant at a 10 % level. In all cases, when expres-
sion was evaluated in the absence of IA, levels decreased 
in comparison with values reported when the inducer of the 
system was used. The initial amount of tryptophan used in 
the culture medium (20 mg/ml) had inhibiting effects.
Analyzing the influence of the concentration of the induc-
tor on the cellular growth and the level of expression (figure 
1), it was demonstrated that a general only rule for predic-
ting the results doesn’t exist. Using similar expression vec-
tors, cultivation medium and conditions of similar growth 
in all the cases, the obtained results are different for each 
of the analyzed proteins. Using concentrations higher than 
or equal to 20 mg/ml of IA the level of obtained expression 
turned out to be independent of the concentration of the 
inductor used (Figure 1b). An exception is the gag-24 pro-
tein, which doesn’t correspond with the previous results 
reported in the literature, asserting that a concentration 
higher than 25 mg/ml decreases the productivity and the 
expression of the recombinant proteins drastically (20, 21, 
22, 23, 24). These points to evidence those others factors 
could be influencing in the process.
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Figure 1. Effect of different concentration of IA on growth 
(A) and expression level (B). Cultures were performed in 
shake flasks, using M9 medium (15) supplemented with 
glucose 20 g/l, casein hydrolysate 10 g/l, and ampicillin 50 
mg/ml. Cultivations were performed at a temperature of 37oC 
and stirrer speed of 250 rpm. The pH was not controlled 
and culture time was 12 hours. The effect of IA concentra-
tion was determined by adding 20 mg/ml of tryptophan 
to the culture medium, and plus different concentrations 
of IA (0 to 60 mg/ml), added after 1hour of cultivation. 
In some proteins, like for example, the gp-41 and the gag-
24, when the process was carried out in absence of the 
inductor, was observed that the level of expression fell 
drastically, because an initial concentration 20 mg/ml of 
tryptophan in the cultural medium had a totally repression 
effect of the tryptophan promoter (25, 26). This agree with 
the previous reports of other authors (1), while the expres-
sion of the gp-120 and gp-36 proteins was only affected 
slightly, for what in some cases the tryptophan promoter 
behaved like constitutive and in other cases like regula-
ted (19). This evidences that the influence of the inductor 
concentration in the production of recombinant proteins 
obtained through a genetic construction, in which the gene 
of interest is inserted in a plasmid under the control of the 
tryptophan promoter, depends on diverse factors, funda-
mentally on the particular characteristics of the cloned 
proteins, as well as of the host strain used (11, 25).
The expression level of different proteins was studied in 
the absence of IA. Initial tryptophan concentration did not 
have a great influence on cellular growth (Figure 2a). For 
all cases in the interval between 20 to 100 mg/ml of tryp-
tophan, optical density was almost constant, while in the 
interval of 0 to 20 mg/ml, cell growth had a slight reduc-
tion for gp-36 and gp-41. The percentage of expression 
of gp-36 and gp-120 decreases slightly (to 10% and 40% 
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respectively), as the initial concentration of the repres-
sor in the culture medium is increased from 0 to 20 mg/ml 
(Figure 2b). Concentrations above this level, however, do 
not influence the protein expression appreciably. In the 
cases of gag-24 and gp-41, the absence of tryptophan in 
the culture medium led to the highest levels of expression 
(more than 25%). Addition of 20 mg/ml of tryptophan is 
enough to reduce drastically the total amount of synthe-
sized protein. In all cases, the best yields were obtained 
when the expressions of the recombinant proteins were 
performed in the absence of IA and tryptophan.
20
                                         A                                                                          B
Figure 2. Effect of different concentration of tryptophan on growth (A) and expression level (B). Cultures were 
performed in shake flasks, using M9 medium (15) supplemented with glucose 20 g/l, casein hydrolysate 10 g/l,
and ampicillin 50 µg/ml. Cultivations were performed at a temperature of 37oC and stirrer speed of 250 rpm. 
The pH was not controlled and culture time was 12 hours. The influence of the initial tryptophan concentrations 
(0 to 100 µg/ml) on protein expression was studied in the absence of IA in the culture medium. 
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Figure 2. Effect of different concentration of tryptophan on 
growth (A) and expression level (B). Cultures were performed 
in shake flasks, using M9 mediu  (15) supplemented with 
glu ose 20 g/l, c sein hydr lys te 10 g/l, and mpicillin 50 
mg/ml. Cultivations w re performed at a t mperature of 37oC 
and stirrer speed of 250 rpm. The pH was not controlled and 
culture time was 12 hours. The influence of the initial trypto-
phan concentrations (0 to 100 mg/ml) on protein expression 
was studied in the absence of IA in the culture medium. 
Upon analyzing the influence of the concentration of the 
repressor on the expression level, it was demonstrated 
that in general terms, in absence of tryptophan, high va-
lues of expression in all cases take place (Figure 2b), com-
pared with those obtained while carrying out the induction 
using IA. On the other hand, when high concentrations 
were used, the level of expression was affected in different 
degree, depending on the expressed protein. In the case 
of the gp-36 and gp-120 proteins, high levels of expres-
sion were observed in presence of high concentrations 
of tryptophan, since it is known that the repression of the 
tryptophan promoter is incomplete (11). 
Otherwise, when using high concentrations of tryptophan 
(20-100 µg/ml), the level of expression was affected totally 
in the case of the proteins gp-41 gag-24 and only slightly 
in the case of the gp-36 and gp-120 proteins.
The levels of expression obtained with these clones were 
higher than 15% for each one of the tested proteins. These 
results are very superior to those reported previously for 
the several proteins of the HIV, like for example, the gp-41 
and the gp-36 proteins (27), the gp-120 (28) and the gag-
24 (29).
Finally we decided to carry out the production of the pro-
teins by derepresion of the expression system, without the 
use of tryptophan in the cultivation medium.
When the tryptophan promoter is used for the expres-
sion of recombinant proteins in E. coli, although similar 
conditions could be used in the case of the expression 
vector, medium and cultivation conditions, it is essential 
to analyze case by case the influence of the inductor’s 
and repressor’s concentrations on the production of the 
protein of interest, in order to select the most favorable 
induction conditions. Finally, it was demonstrated that for 
each protein, there is a defined concentration of IA and 
tryptophan, which maximizes its production. These proce-
dures could be also applied to production of other recom-
binant proteins expressed in E. coli under the control of 
tryptophan promoters.
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